Iron and atherosclerosis

Clinical Cardiology

Volumn 28, Issue 3, 2005, Pages 119-122

  Qayyum, Rehan ^a   Schulman, Peter ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Atherosclerosis; Blood donation; Coronary artery disease; Ferritin; Iron; Oxidation

Indexed keywords

ESTROGEN; FERRITIN; GESTAGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE SYNTHASE; ORAL CONTRACEPTIVE AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSFERRIN RECEPTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL MEMBRANE; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ELECTRON TRANSPORT; ENDURANCE; EPIDEMIOLOGICAL DATA; HEALTH SURVEY; HEMOCHROMATOSIS; HETEROZYGOTE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; IRON DEFICIENCY ANEMIA; IRON INTAKE; LIPID BLOOD LEVEL; LIPID OXIDATION; MENOPAUSE; MENSTRUATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHLEBOTOMY; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; SEX RATIO; THROMBOEMBOLISM;

ARTERIOSCLEROSIS; EXERCISE; HEMORRHAGE; HUMANS; IRON; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; RISK FACTORS;

EID: 14944367315     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Leaverton PE, Sorlie PD, Kleinman JC, Dannenberg AL, Ingster-Moore L, Kannel WB, Cornoni-Huntley JC: Representativeness of the Framingham risk model for coronary artery disease mortality: A comparison with national cohort study. J Chron Dis 1987;40:775-784
2. Sullivan JL: Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-1294
3. Sullivan JL: The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-1188
4. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM: Association of age, sex and race with body iron stores in adults: Analysis of NHANES III data. Am Heart J 2000;140:98-104
5. Gordon T, Kannel WB, Hjortland MC, McNamara PM: Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978;89:157-161
6. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc 1998;280:605-613
7. Writing Group for Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc 2002;288:321-333
8. Frassinelli-Gunderson E, Margen S, Brown JR: Iron stores in users of oral contraceptive agents. Am J Clin Nutr 1985;41:703-712
9. Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD: Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med 1981;305:420-424
10. Sullivan JL: The sex difference in ischemic heart disease. Perspect Biol Med 1983;26:657-671
11. Halliwell B: Reactive oxygen species in living systems: Source, biochemistry, and role in human disease. Am J Med 1991;91:14S-22S
12. Luft R, Landau BR: Mitochondrial medicine. J Intern Med 1995;238:405-421
13. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000;87:840-844
14. Marnett LJ, Riggins JN, West JD: Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest 2003;111:583-593
15. Girotti AW: Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998 Aug;39(8):1529-1542
16. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM: The yin and yang of oxidation in the development of the fatty streak: A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol Med 1996;16:831-842
17. Wood JL, Graham A: Structural requirements for oxidation of low-density lipoprotein by thiols. FEBS Lett 1995;366:75-80
18. Heinecke JW: Oxidant and antioxidants in the pathogenesis of atherosclerosis: Implications for oxidized low density lipoprotein hypothesis. Atherosclerosis 1998;141:1-15
19. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R: Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-2325
20. Li W, Yuan XM, Olsson AG, Brunk UT: Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler Thromb Vasc Biol 1998;18:177-184
21. Skepper JN, Karydis I, Garnett MR, Hegyi L, Hardwick SJ, Warley A, Mitchinson MJ, Cary NR: Changes in elemental concentrations are associated with early stages of apoptosis in human monocyte-macrophages exposed to oxidized low-density lipoprotein: An x-ray microanalytical study. J Pathol 1999;188:100-106
22. Pahl PM, Yan XD, Hodges YK, Rosenthal EA, Horwitz MA, Horwitz LD: An exochelin of Mycobacterium tuberculosis reversibly arrests growth of human vascular smooth muscle cells in vitro. J Biol Chem 2000;275:17821-17826
23. Barradas MA, Jeremy JY, Kontoghiorghes GJ, Mikhailidis DP, Hoffbrand AV, Dandona P: Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity. FEBS Lett 1989;245:105-109
24. Tzonou A, Lagiou P, Trichopoulou A, Tsoutsos V, Trichopoulos D: Dietary iron and coronary heart disease risk: A study from Greece. Am J Epidemiol 1998;147:161-166
25. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ: Dietary iron intake and the risk of coronary artery disease in men. Circulation 1994;89:969-974
26. Morrison HI, Semenciw RM, Mao Y, Wigle DT: Serum iron and risk of fatal acute myocardial infarction. Epidemiology 1994;5:243-246
27. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-811
28. Guyatt GH, Patterson C, Ali M, Singer J, Levine M, Turpie I, Meyer R: Diagnosis of iron-deficiency anemia in the elderly. Am J Med 1990;88:205-209
29. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F: Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study. Circulation 1997;96:3300-3307
30. Suominen P, Punnonen K, Rajamaki A, Irjala K: Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 1998;92:2934-2939
31. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT: Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97:1461-1466
32. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP: Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-1805
33. Tuomainen T, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT: Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: A prospective cohort study in men in eastern Finland. Circulation 1999;100:1274-1279
34. Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, Sixma JJ, Banga JD: Heterozygosity for hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 199;100:1268-1273
35. Maioli M, Pettinato S, Cherchi GM, Giraudi D, Pacifico A, Pupita G, Tidore MG: Plasma lipids in beta-thalassemia minor. Atherosclerosis 1989;75:245-248
36. Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, D'Arpa D, D'Anna R, Bongiorno A: Oxidative stress and antioxidant status in beta-thalassemia major: Iron overload and depletion of lipid soluble antioxidants. Blood 1996;88:3608-3614
37. Livrea MA, Tesoriere L, Maggio A, D'Arpa D, Pintaudi AM, Pedone E: Oxidative modification of low-density lipoprotein and atherogenetic risk in beta-thalassemia. Blood 1998;92:3936-3942
38. Tuomainen T, Salonen R, Nyyssonen K, Salonen JT: Cohort study of relations between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. Br Med J 1997;314:793-794
39. Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF: Possible association of reduction in cardiovascular events with blood donation. Heart 1997;78:188-193
40. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ: Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52-57
41. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS: Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med 1988;319:1379-1384
42. Nielson P, Nachtigall D: Iron supplementation in athletes: Current recommendations. Sports Med 1998;26:207-217
43. Lakka TA, Nyyssonen K, Salonen JT: Higher levels of conditioning leisure time physical activity are associated with reduced levels of stored iron in Finnish men. Am J Epidemiol 1994;140:148-160
44. Baer DM, Tekawa IS, Hurley LB: Iron stores are not associated with acute myocardial infarction. Circulation 1994;89:2915-2918
45. Sempos CT, Looker AC, Gillum RF, Makuc DM: Body iron stores and the risk of coronary artery disease. N Engl J Med 1994;330:1119-1124
46. Manfroi WC, Zago AJ, Cruz R, Oliveira J, Kirschnick LS, Ordovas K, Candiago RH, Souza J, Ribeiro LW, Leitao C, Brizolara ML: Lack of relationship between serum ferritin levels and coronary atherosclerosis evaluated by coronary angiography. Braz J Med Biol Res 1999;32:303-307
47. Danesh J, Appleby P: Coronary heart disease and iron status: Meta analyses of prospective studies. Circulation 1999;99:852-854
48. Http://clinicaltrials.gov/show/NCT00032357 (accessed 05/23/04)